We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study.
- Authors
Ahern, T; Tobin, A-M; Corrigan, M; Hogan, A; Sweeney, C; Kirby, B; O'Shea, D
- Abstract
Diabetes and obesity are more prevalent amongst psoriasis patients as is disturbance of the innate immune system. GLP-1 analogue therapy considerably improves weight and glycaemic control in people with type 2 diabetes and its receptor is present on innate immune cells.
- Publication
Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Vol 27, Issue 11, p1440
- ISSN
1468-3083
- Publication type
Journal Article
- DOI
10.1111/j.1468-3083.2012.04609.x